Caplin Point Laboratories informs about press release

05 Feb 2025 Evaluate
Caplin Point Laboratories has informed that Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Procainamide Hydrochloride Injection USP, 1g/10mL and 1g/2mL Vials, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) PRONESTYL, from Apothecon Inc.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1797.80 -43.40 (-2.36%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×